Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
Introduction. Corneal neovessels are a major risk factor for corneal graft rejection, due to the loss of the immune privilege. The purpose of this study is to evaluate the effectiveness of intrastromal injection of bevacizumab in the treatment of corneal neovascularization. Material and Methods. Thi...
Saved in:
Main Authors: | Belghmaidi Sarah, Hajji Ibtissam, Baali Mohammed, Soummane Hasna, Moutaouakil Abdeljalil |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2016/6084270 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
by: Deli Krizova, et al.
Published: (2014-01-01) -
Efficacy of Voriconazole Corneal Intrastromal Injection for the Treatment of Fungal Keratitis
by: Chenshuang Li, et al.
Published: (2021-01-01) -
Corneal Debridement Combined with Intrastromal Voriconazole for Recalcitrant Fungal Keratitis
by: Yajie Sun, et al.
Published: (2018-01-01) -
Extrusion of Femtosecond Laser-Implanted Intrastromal Corneal Ring Segments in Keratoconic Eyes: Prevalence, Risk Factors, and Clinical Outcomes
by: Amr Mounir, et al.
Published: (2020-01-01) -
Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
by: Zongyi Wang, et al.
Published: (2020-01-01)